1. Home
  2. CLDI vs MIGI Comparison

CLDI vs MIGI Comparison

Compare CLDI & MIGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Calidi Biotherapeutics Inc.

CLDI

Calidi Biotherapeutics Inc.

HOLD

Current Price

$1.52

Market Cap

9.9M

Sector

Health Care

ML Signal

HOLD

Logo Mawson Infrastructure Group Inc.

MIGI

Mawson Infrastructure Group Inc.

HOLD

Current Price

$4.80

Market Cap

8.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLDI
MIGI
Founded
2014
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
9.9M
8.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CLDI
MIGI
Price
$1.52
$4.80
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
217.9K
174.3K
Earning Date
11-13-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$51,587,942.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.10
$4.40
52 Week High
$26.04
$40.00

Technical Indicators

Market Signals
Indicator
CLDI
MIGI
Relative Strength Index (RSI) 52.61 74.93
Support Level $1.38 $4.50
Resistance Level $1.55 $5.05
Average True Range (ATR) 0.09 0.55
MACD 0.02 0.27
Stochastic Oscillator 92.42 70.11

Price Performance

Historical Comparison
CLDI
MIGI

About CLDI Calidi Biotherapeutics Inc.

Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.

About MIGI Mawson Infrastructure Group Inc.

Mawson Infrastructure Group Inc is a digital infrastructure provider with diversified operations across Cryptocurrency Mining and Digital Asset Management. Its mission is to build a bridge between the rapidly emerging digital asset industry and traditional capital markets, with a focus on shareholder returns. The Company has three primary businesses: digital currency or Bitcoin self-mining, customer co-location and related services, and energy markets. It operates in a single segment surrounding its digital currency mining operation.

Share on Social Networks: